{
  "id": "cde2aa968d3cc6ad",
  "title": "Cereno Scientific Receives FDA Clearance to Initiate Global Phase IIb Trial of CS1 in Pulmonary Arterial Hypertension ( PAH ) ",
  "description": "20251208T223000Z",
  "content": "",
  "source": "finanznachrichten.de",
  "source_url": "https://www.finanznachrichten.de/nachrichten-2025-12/67177264-cereno-scientific-receives-fda-clearance-to-initiate-global-phase-iib-trial-of-cs1-in-pulmonary-arterial-hypertension-pah-008.htm",
  "published_at": "20251208T223000Z",
  "fetched_at": "2025-12-09T00:22:19.510482+00:00",
  "category": "macroeconomics_finance",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "Germany",
  "raw_data": {
    "url": "https://www.finanznachrichten.de/nachrichten-2025-12/67177264-cereno-scientific-receives-fda-clearance-to-initiate-global-phase-iib-trial-of-cs1-in-pulmonary-arterial-hypertension-pah-008.htm",
    "url_mobile": "",
    "title": "Cereno Scientific Receives FDA Clearance to Initiate Global Phase IIb Trial of CS1 in Pulmonary Arterial Hypertension ( PAH ) ",
    "seendate": "20251208T223000Z",
    "socialimage": "",
    "domain": "finanznachrichten.de",
    "language": "English",
    "sourcecountry": "Germany"
  }
}